Yunzhao Xiong

Shijiazhuang, 050200, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Esaxerenone Attenuates Aldosterone-Induced Renal Fibrosis by Suppressing Fibroblast-to-Lymphatic Endothelial-like Cell Transdifferentiation.

Esaxerenone Attenuates Aldosterone-Induced Renal Fibrosis by Suppressing Fibroblast-to-Lymphatic Endothelial-like Cell Transdifferentiation.

Journal: International journal of molecular sciences

Published: March 30, 2026

Aldosterone-Induced Renal Lymphangiogenesis and Endothelial-To-Mesenchymal Transformation to Promote Renal Interstitial Fibrosis Through the MR/TGF-β1 Pathway in Mice.

Aldosterone-Induced Renal Lymphangiogenesis and Endothelial-To-Mesenchymal Transformation to Promote Renal Interstitial Fibrosis Through the MR/TGF-β1 Pathway in Mice.

Journal: Frontiers in bioscience (Landmark edition)

Published: August 06, 2025

Aldosterone induces renal lymphangiogenesis through macrophage-lymphatic endothelial cell transformation and Inhibition by esaxerenone.

Aldosterone induces renal lymphangiogenesis through macrophage-lymphatic endothelial cell transformation and Inhibition by esaxerenone.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: February 03, 2025

Fibroblast to macrophage-like cell transition in renal inflammatory injury through the MR/CSF1 pathway induced by aldosterone.

Fibroblast to macrophage-like cell transition in renal inflammatory injury through the MR/CSF1 pathway induced by aldosterone.

Journal: Life sciences

Published: January 27, 2025

Proliferation of renal macrophage via MR/CSF1 pathway induced with aldosterone and inhibited by esaxerenone.

Proliferation of renal macrophage via MR/CSF1 pathway induced with aldosterone and inhibited by esaxerenone.

Journal: International immunopharmacology

Published: January 07, 2025

Inhibitory effects of Eplerenone on angiogenesis via modulating SGK1/TGF-β pathway in contralateral kidney of CKD pregnancy rats.

Inhibitory effects of Eplerenone on angiogenesis via modulating SGK1/TGF-β pathway in contralateral kidney of CKD pregnancy rats.

Journal: Cellular signalling

Published: March 12, 2024

Eplerenone reduces lymphangiogenesis in the contralateral kidneys of UUO rats.

Eplerenone reduces lymphangiogenesis in the contralateral kidneys of UUO rats.

Journal: Scientific reports

Published: December 06, 2023

Eplerenone Prevents Cardiac Fibrosis by Inhibiting Angiogenesis in Unilateral Urinary Obstruction Rats.

Eplerenone Prevents Cardiac Fibrosis by Inhibiting Angiogenesis in Unilateral Urinary Obstruction Rats.

Journal: Journal of the renin-angiotensin-aldosterone system : JRAAS

Published: June 16, 2022

Esaxerenone inhibits the macrophage-to-myofibroblast transition through mineralocorticoid receptor/TGF-β1 pathway in mice induced with aldosterone.

Esaxerenone inhibits the macrophage-to-myofibroblast transition through mineralocorticoid receptor/TGF-β1 pathway in mice induced with aldosterone.

Journal: Frontiers in immunology

Published: May 20, 2022

Eplerenone ameliorates lung fibrosis in unilateral ureteral obstruction rats by inhibiting lymphangiogenesis.

Eplerenone ameliorates lung fibrosis in unilateral ureteral obstruction rats by inhibiting lymphangiogenesis.

Journal: Experimental and therapeutic medicine

Published: April 28, 2022

The IFNγ-PDL1 Pathway Enhances CD8T-DCT Interaction to Promote Hypertension.

The IFNγ-PDL1 Pathway Enhances CD8T-DCT Interaction to Promote Hypertension.

Journal: Circulation research

Published: April 18, 2022

Eplerenone inhibits UUO-induced lymphangiogenesis and cardiac fibrosis by attenuating inflammatory injury.

Eplerenone inhibits UUO-induced lymphangiogenesis and cardiac fibrosis by attenuating inflammatory injury.

Journal: International immunopharmacology

Published: October 13, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026